Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

TACO and TRALI: biology, risk factors, and prevention strategies.

Roubinian N.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):585-594. doi: 10.1182/asheducation-2018.1.585. Epub 2018 Dec 14.

PMID:
30570487
2.

Long-Term Outcomes Among Patients Discharged From the Hospital With Moderate Anemia: A Retrospective Cohort Study.

Roubinian NH, Murphy EL, Mark DG, Triulzi DJ, Carson JL, Lee C, Kipnis P, Kleinman S, Liu VX, Escobar GJ.

Ann Intern Med. 2018 Dec 18. doi: 10.7326/M17-3253. [Epub ahead of print]

PMID:
30557414
3.

Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Karafin MS, Tan S, Tormey CA, Spencer BR, Hauser RG, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE.

Transfusion. 2019 Jan;59(1):217-225. doi: 10.1111/trf.15004. Epub 2018 Nov 14.

PMID:
30427537
4.

Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease.

Carson JL, Stanworth SJ, Alexander JH, Roubinian N, Fergusson DA, Triulzi DJ, Goodman SG, Rao SV, Doree C, Hebert PC.

Am Heart J. 2018 Jun;200:96-101. doi: 10.1016/j.ahj.2018.04.007. Epub 2018 Apr 7.

PMID:
29898855
5.

Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.

Karafin MS, Westlake M, Hauser RG, Tormey CA, Norris PJ, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Hendrickson JE; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Br J Haematol. 2018 Jun;181(5):672-681. doi: 10.1111/bjh.15182. Epub 2018 Apr 19.

PMID:
29675950
6.

Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.

Roubinian NH, Hendrickson JE, Triulzi DJ, Gottschall JL, Michalkiewicz M, Chowdhury D, Kor DJ, Looney MR, Matthay MA, Kleinman SH, Brambilla D, Murphy EL; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Crit Care Med. 2018 Apr;46(4):577-585. doi: 10.1097/CCM.0000000000002948.

PMID:
29300236
7.

Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.

Karafin MS, Bruhn R, Westlake M, Sullivan MT, Bialkowski W, Edgren G, Roubinian NH, Hauser RG, Kor DJ, Fleischmann D, Gottschall JL, Murphy EL, Triulzi DJ; National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Transfusion. 2017 Dec;57(12):2903-2913. doi: 10.1111/trf.14370. Epub 2017 Oct 24.

8.

Differentiating pulmonary transfusion reactions using recipient and transfusion factors.

Roubinian NH, Looney MR, Keating S, Kor DJ, Lowell CA, Gajic O, Hubmayr R, Gropper M, Koenigsberg M, Wilson GA, A Matthay M, Toy P, Murphy EL; TRALI Study Group.

Transfusion. 2017 Jul;57(7):1684-1690. doi: 10.1111/trf.14118. Epub 2017 May 3.

9.

Statistical Caution in Big Data Approaches to Transfusion Medicine Research.

Roubinian N, Brambilla D, Murphy EL.

JAMA Intern Med. 2017 Jun 1;177(6):860-861. doi: 10.1001/jamainternmed.2017.0914. No abstract available.

PMID:
28437522
10.

Adjusting the Focus on Transfusion-associated Circulatory Overload.

Roubinian N, Murphy EL.

Anesthesiology. 2017 Mar;126(3):363-365. doi: 10.1097/ALN.0000000000001507. No abstract available.

PMID:
28072600
11.

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC.

Cochrane Database Syst Rev. 2016 Oct 12;10:CD002042. Review.

PMID:
27731885
12.

Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication.

Hendrickson JE, Roubinian NH, Chowdhury D, Brambilla D, Murphy EL, Wu Y, Ness PM, Gehrie EA, Snyder EL, George Hauser R, Gottschall JL, Kleinman S, Kakaiya R, Strauss RG; National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Transfusion. 2016 Oct;56(10):2587-2596. doi: 10.1111/trf.13730. Epub 2016 Jul 26.

13.

Red Blood Cell Transfusion Strategies in Adult and Pediatric Patients with Malignancy.

Roubinian N, Carson JL.

Hematol Oncol Clin North Am. 2016 Jun;30(3):529-40. doi: 10.1016/j.hoc.2016.01.001. Epub 2016 Feb 18. Review.

PMID:
27112994
14.

2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium.

Spitalnik SL, Triulzi D, Devine DV, Dzik WH, Eder AF, Gernsheimer T, Josephson CD, Kor DJ, Luban NL, Roubinian NH, Mondoro T, Welniak LA, Zou S, Glynn S; State of the Science in Transfusion Medicine Working Groups.

Transfusion. 2015 Sep;55(9):2282-90. doi: 10.1111/trf.13250. Epub 2015 Aug 10.

15.

Restrictive red blood cell transfusion strategies appear safe in most clinical settings.

Roubinian NH, Carson JL.

Evid Based Med. 2015 Oct;20(5):170. doi: 10.1136/ebmed-2015-110218. Epub 2015 Jul 28. No abstract available.

PMID:
26220955
16.

Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions.

Roubinian NH, Looney MR, Kor DJ, Lowell CA, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson GA, Matthay MA, Toy P, Murphy EL; TRALI Study Group.

Transfusion. 2015 Aug;55(8):1838-46. doi: 10.1111/trf.13021. Epub 2015 Feb 23.

17.

Shedding a little light on posttransfusion purpura.

Roubinian NH, Leavitt AD.

Transfusion. 2015 Feb;55(2):232-4. doi: 10.1111/trf.12934. No abstract available.

PMID:
25683186
18.

A multicenter study of plasma use in the United States.

Triulzi D, Gottschall J, Murphy E, Wu Y, Ness P, Kor D, Roubinian N, Fleischmann D, Chowdhury D, Brambilla D; NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

Transfusion. 2015 Jun;55(6):1313-9; quiz 1312. doi: 10.1111/trf.12970. Epub 2014 Dec 19.

19.

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients.

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Transfusion. 2014 Oct;54(10 Pt 2):2678-86. doi: 10.1111/trf.12825. Epub 2014 Aug 18.

20.

Decreased red blood cell use and mortality in hospitalized patients.

Roubinian NH, Escobar GJ, Liu V, Gardner MN, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

JAMA Intern Med. 2014 Aug;174(8):1405-7. doi: 10.1001/jamainternmed.2014.2889. No abstract available.

Supplemental Content

Loading ...
Support Center